A Novel Founder CHEK2 Mutation is Associated with Increased Prostate Cancer Risk

Cezary Cybulski, Tomasz Huzarski, Bohdan Górski, +13

Cancer Research

Chek2 GeneUrologyCancer RiskCancer EpidemiologyPolish Patients +10

The spectrum of mutations predisposing to familial breast cancer in Poland

Cezary Cybulski, Wojciech Kluźniak, Tomasz Huzarski, +18

International Journal of Cancer

<i>BRCA1</i> promoter methylation in peripheral blood is associated with the risk of triple‐negative breast cancer

Karolina Prajzendanc, Paweł Domagała, Jolanta Hybiak, +18

International Journal of Cancer

Mutations in <scp><i>ATM</i></scp>, <scp><i>NBN</i></scp> and <scp><i>BRCA2</i></scp> predispose to aggressive prostate cancer in Poland

Dominika Wokołorczyk, Wojciech Kluźniak, Tomasz Huzarski, +15

International Journal of Cancer

Recurrent mutations of <scp>BRCA1</scp> and <scp>BRCA2</scp> in Poland: an update

Marek Szwiec, Anna Jakubowska, Bohdan Górski, +12

Clinical Genetics

BiologyGenome InstabilityRecurrent MutationsSomatic VariantBreast Oncology +11

PALB2 mutations and prostate cancer risk and survival

Dominika Wokołorczyk, Wojciech Kluźniak, Klaudia Stempa, +52

British Journal of Cancer

UrologyMedicineProstatic DiseasePalb2 MutationsCancer Genetics +1

BARD1 is a Low/Moderate Breast Cancer Risk Gene: Evidence Based on an Association Study of the Central European p.Q564X Recurrent Mutation

Malwina Suszyńska, Wojciech Kluźniak, Dominika Wokołorczyk, +13

Cancers

Serum Selenium Level Predicts 10-Year Survival after Breast Cancer

Marek Szwiec, Wojciech Marciniak, Róża Derkacz, +13

Nutrients

Recurrent Mutations in BRCA1, BRCA2, RAD51C, PALB2 and CHEK2 in Polish Patients with Ovarian Cancer

Alicja Łukomska, Janusz Menkiszak, Jacek Gronwald, +19

Cancers

Students’ Knowledge about Cervical Cancer Prevention in Poland

Karolina Osowiecka, Samira Yahuza, Marek Szwiec, +8

Medicina